November 2013 FDA Recall Drug by Greenstone Llc
D-1059-2014 - Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval

This Class III drug recall was voluntarily initiated by Greenstone Llc on November 4, 2013 for the product Drug. The FDA reported the reason for recall as failed dissolution specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1059-2014

Reason for Recall
Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval
Initiated
11-04-2013
Reported
02-12-2014
Quantity
22,529 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
US Nationwide (including PR)
Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2

Batch or Lot Expiration Information

Lot# lot V112000, EXP Jun 2016